These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7475445)

  • 1. [Trends of prevalence of HIV infection in a cohort of parenteral drug users].
    Bolao F; Ramón JM
    Med Clin (Barc); 1995 Sep; 105(10):396. PubMed ID: 7475445
    [No Abstract]   [Full Text] [Related]  

  • 2. An analysis of the effects of HIV infection in a cohort of intravenous drug users.
    O'Kelly FD; Bury G
    Ir Med J; 1996; 89(3):112-4. PubMed ID: 8707519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV-infection and AIDS in the Netherlands: prevalence and incidence, 1987-2001].
    Op de Coul EL; Beuker RJ; Prins M; Fennema JS; van der Meijden WI; Coutinho RA; van de Laar MJ
    Ned Tijdschr Geneeskd; 2003 May; 147(22):1071-6. PubMed ID: 12814020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.
    Muga R; Sanvisens A; Egea JM; Tor J; Rey-Joly C
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S404-9. PubMed ID: 14648455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A cohort study of HIV infection among intravenous drug users in Ruili and other two counties in Yunnan Province, China, 1992-1995].
    Zheng X; Zhang JP; Qu SQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Oct; 18(5):259-62. PubMed ID: 9812484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The incidence of human immunodeficiency virus type-1 (HIV-1) infection in parenteral drug users].
    Aviñó Rico MJ; Hernández Aguado I; Pérez Hoyos S; García de la Hera M; Ruiz I; Bolumar Montrull F
    Med Clin (Barc); 1994 Mar; 102(10):369-73. PubMed ID: 8182982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in HIV prevalence among drug-users attending public drug-treatment centres in Italy: 1990-2000.
    Suligoi B; Magliochetti N; Nicoletti G; Pezzotti P; Rezza G
    J Med Virol; 2004 May; 73(1):1-6. PubMed ID: 15042640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing HIV prevalence among drug users in western Guangdong province, China, 1995-2005.
    Fu X; Wang Y; Lin P; Liu Y; He Q; Li Y; Yang F; Li J; Diao L; Yan X; Lin P; Zhao J; Chen S; McFarland W
    AIDS Behav; 2008 Jul; 12(4 Suppl):S13-6. PubMed ID: 18389359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cohort study of HIV infection among drug users in Ruili City and Longchuan County, Yunnan Province, China].
    Zheng X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):3-5. PubMed ID: 8504451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of human immunodeficiency virus infection and behaviors associated with its transmission among parenteral drug users selected on the street].
    Rodés A; Vall M; Casabona J; Nuez M; Rabella N; Mitrani L
    Med Clin (Barc); 1998 Oct; 111(10):372-7. PubMed ID: 9833239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.
    Platt L; Bobrova N; Rhodes T; Uusküla A; Parry JV; Rüütel K; Talu A; Abel K; Rajaleid K; Judd A
    AIDS; 2006 Oct; 20(16):2120-3. PubMed ID: 17053361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The survey of HIV prevalence among drug users in Guangxi, China].
    Zhang G; Zheng X; Liu W; Liang F; Qu S; Mao Y; Wang L; Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):15-6. PubMed ID: 11860749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trends in HIV prevalence and risk behaviour among injecting drug users in Rotterdam, I994-2002].
    de Boer IM; Op de Coul EL; Beuker RJ; de Zwart O; Al Taqatqa W; van de Laar MJ
    Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2325-30. PubMed ID: 15587051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of human immunodeficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center].
    Dolcini G; Ambrosioni J; Andreani G; Pando MA; Martínez Peralta L; Benetucci J
    Rev Argent Microbiol; 2008; 40(3):164-6. PubMed ID: 19024504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of prevalence of HIV-1 infection among injection drug users in Montreal, Quebec.
    Lamothe F; Bruneau J; Soto J; Vincelette J; Brabant M; Lachance N; Fauvel M
    Can Commun Dis Rep; 1992 Jul; 18(13):98-101. PubMed ID: 1364884
    [No Abstract]   [Full Text] [Related]  

  • 18. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
    de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
    Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.